LSTA: Lisata Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 17.66
Enterprise Value ($M) -2.81
Book Value ($M) 25.10
Book Value / Share 2.99
Price / Book 0.70
NCAV ($M) 24.74
NCAV / Share 2.94
Price / NCAV 0.71

Profitability (mra)
Return on Invested Capital (ROIC) -0.77
Return on Assets (ROA) -0.40
Return on Equity (ROE) -0.45

Liquidity (mrq)
Quick Ratio 7.52
Current Ratio 7.52

Balance Sheet (mrq) ($M)
Current Assets 28.62
Assets 28.98
Liabilities 3.88
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1.00
Operating Income -22.41
Net Income -19.98
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Basic And Diluted Since Acquisition n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -19.36
Cash from Investing 13.23
Cash from Financing -0.21

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-09 2,626 17,762 14.78
2025-05-08 611 3,795 16.10
2025-05-07 394 5,152 7.65
2025-05-06 609 8,011 7.60
2025-05-05 3,842 6,070 63.29

(click for more detail)

Similar Companies
LPCN – Lipocine Inc. LPTX – Leap Therapeutics, Inc.
LQDA – Liquidia Corporation LTRN – Lantern Pharma Inc.
MBIO – Mustang Bio, Inc.


Financial data and stock pages provided by
Fintel.io